2023
DOI: 10.5152/eurjrheum.2022.21097
|View full text |Cite
|
Sign up to set email alerts
|

Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles